Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
PhoreMost Enters Multi-project Drug Target Discovery Collaboration With Roche
PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced […]
Coave Therapeutics Strengthens Leadership Team with the Appointments of Catherine Mathis as Vice President Regulatory Affairs and Julien Berger as Head of Legal Affairs
Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS […]
Dong-A ST and Beactica Therapeutics Mutually Agree to Conclude Oncology Collaboration
Dong-A ST Co., Ltd. (170900: Korea SE), a Korean pharmaceutical company, and Beactica Therapeutics AB, […]
Lytix Biopharma Appoints Stephen Worsley as Chief Business Officer
Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immune-oncology company, today announces the appointment […]
Novo Nordisk to Acquire Forma Therapeutics and Expand Presence in Sickle Cell Disease and Rare Blood Disorders
Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered […]
RaySearch and Leo Cancer Care Join Forces to Enable Upright Radiotherapy
A key milestone and partnership for the clinical implementation of upright radiotherapy has been announced. […]
Ibex and Medipath Sign Multi-Year, Multi-Site and Multi-Tissue Expansion of AI for Cancer Diagnosis Across France
Ibex Medical Analytics, the leader in AI-powered cancer diagnostics, and Medipath, the largest network of private […]
eCential Robotics Receives FDA Clearance for Its Surgical Robotic Platform for Spine Surgery
eCential Robotics, a French growth MedTech company that designs and produces a system unifying 2D/3D […]
Spatial Biology CRO Flagship Biosciences Acquires Pharma Services Business from Interpace Biosciences
Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition […]
Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator
Mayo Clinic, Hibiscus BioVentures (Hibiscus) and Innoforce announce the launch of Mayflower BioVentures, a cell and gene therapy […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more